Moderna Inc's (NASDAQ: MRNA) clinical trial data from its research assay confirm that its updated COVID-19 vaccine generates an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86 (Pirola),
Williams' (NYSE:WMB) board of directors has approved a regular dividend of $0.4475 per share, or $1.79 annualized, on the company's common stock, payable on March 27, 2023, to holders of record at the close of business on March 13, 2023.